Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04087980 · ClinicalTrials.gov registry record · NA
Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer
A NA study of Prostate Cancer, sponsored by Francis Medical.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 5
- Study locations
NCT04087980: Completed NA study of Prostate Cancer, sponsored by Francis Medical.
NCT04087980 is a NA study of Prostate Cancer that has completed, run by Francis Medical. The registered enrollment target is 26 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04087980, a NA study of Prostate Cancer, has completed, sponsored by Francis Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this research study is to collect information on a new treatment of prostate tissue participants with intermediate risk prostate cancer using a medical device called the Poseidon System. The Poseidon System is intended to ablate prostate tissue in areas of the prostate where cancer has been identified. The medical device delivers thermal energy in the form of water vapor to the prostate tissue through the urethra. Previous research has shown successful prostate tissue ablation. Additional research may help show successful ablation of the prostate tissue where cancer is located.
Conditions Studied
Interventions
- DEVICE Poseidon System
Study Locations (5)
Minnesota
- University of Minnesota - Minneapolis
- Minnesota Urology - Woodbury
Maryland
- Chesapeake Urology - Baltimore
New York
- Bon Secours/Good Samaritan Hospital - New York
Texas
- Urology San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-04-10 |
| Est. Completion | 2022-05-25 |
| Phase | NA |
What the finished NCT04087980 record still lists
NCT04087980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Poseidon System is the first listed.
NCT04087980 lists 5 locations in 4 states (Minnesota, Maryland, New York).
Frequently Asked Questions
What is clinical trial NCT04087980 about?
NCT04087980 is a clinical study titled "Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer". The purpose of this research study is to collect information on a new treatment of prostate tissue participants with intermediate risk prostate cancer using a medical device called the Poseidon System. The Poseidon System is intended to ablate prostate tissue in areas of the prostate where cancer ha...
What is the current status of trial NCT04087980?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-04-10. Estimated completion is 2022-05-25.
What conditions does trial NCT04087980 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT04087980?
The interventions under investigation include: Poseidon System (DEVICE).
Who is sponsoring clinical trial NCT04087980?
This trial is sponsored by Francis Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04087980 being conducted?
This trial has 5 study locations across Maryland, Minnesota, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04087980's enrollment target sits among peer trials
26 623rd of 735 higher than 111 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI